Definition:Structured product
🏗️ Structured product in the insurance context refers to a pre-packaged financial instrument — typically combining fixed-income securities, derivatives, and sometimes equity components — that is either held as an investment asset by an insurer, used to back policyholder obligations such as variable annuities or unit-linked policies, or created by insurers and reinsurers as a vehicle to transfer underwriting risk to the capital markets. The term encompasses a wide range of instruments, from collateralized debt obligations and mortgage-backed securities held in insurer general accounts, to insurance-linked securities such as catastrophe bonds that package catastrophe risk into tradable notes, to index-linked savings products sold to retail policyholders. Their defining characteristic is the tailored combination of payoff profiles — engineered to meet specific risk-return, duration-matching, or risk-transfer objectives that plain-vanilla instruments cannot achieve on their own.
⚙️ On the investment side, insurers are significant buyers of structured products because their complex cash flow profiles can be matched to the duration and yield requirements of long-tail life and annuity liabilities. A CLO tranche rated investment grade, for example, may offer a spread premium over comparably rated corporate bonds while fitting within regulatory investment limits. However, the embedded complexity carries risks that regulators monitor closely: under Solvency II, insurers must apply a look-through approach to structured holdings, assessing the underlying asset exposures for capital charge purposes rather than treating the wrapper at face value. The NAIC in the United States has similarly tightened scrutiny of structured securities held by insurers, particularly private credit structures originated through affiliated asset managers, introducing modeled risk-based capital charges that reflect actual loss distributions rather than relying solely on rating agency designations. On the risk-transfer side, the creation of structured products like catastrophe bonds involves establishing a special purpose vehicle that issues notes to investors and uses the proceeds as collateral against specified insurance loss triggers — a mechanism that allows reinsurers and primary insurers to access capital market capacity beyond the traditional reinsurance market.
💡 The intersection of structured products and insurance has been shaped by hard lessons. The 2008 financial crisis exposed the dangers of insurers holding concentrated positions in opaque structured credit instruments — most notably at AIG, whose Financial Products unit wrote credit default swaps on structured mortgage portfolios, ultimately triggering one of the largest government bailouts in history. That episode led to fundamental reforms in how regulators evaluate insurer exposures to structured products, including enhanced stress testing, stricter asset valuation standards, and greater transparency requirements. Today, structured products remain integral to insurance investment strategies and risk management, but under far more rigorous oversight. For insurtech platforms and asset managers serving the insurance sector, the ability to model, report, and monitor structured product exposures — accounting for look-through requirements, spread risk charges, and concentration limits across different regulatory regimes — represents a critical capability. Meanwhile, the ILS market continues to grow as a structured mechanism for efficiently channeling investor capital toward peak natural catastrophe risks, demonstrating the enduring utility of well-designed structured products when transparency and governance are maintained.
Related concepts: